Key facts
- The Senate Health Committee advanced Dr. Erica Schwartz's nomination for CDC Director.
- Concerns about political interference in public health decisions were raised.
- Senator Bill Cassidy's support was key after discussions with Schwartz.
- Senator Bernie Sanders opposed the nomination due to concerns about anti-science influences.
- The CDC has lost over a quarter of its workforce and experienced leadership instability.
- Schwartz pledged to uphold scientific integrity but did not fully commit to rejecting all political directives.
The U.S. Senate health committee voted to advance the nomination of Dr. Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC), marking a potential win for the Trump administration after previous unsuccessful attempts to fill top health positions. The nomination, along with that of Sean Kaufman for Assistant Secretary, was sent to the full Senate by a 13-10 vote.
Schwartz's nomination faced scrutiny over her ability to resist political interference from the Trump administration, particularly from Health Secretary Robert F. Kennedy Jr. Committee Chairman Sen. Bill Cassidy, R-La., initially expressed reservations but ultimately supported Schwartz following discussions, stating confidence in her capacity to withstand undue influence. Sen. Bernie Sanders, I-Vt., opposed the nomination, questioning whether nominees would challenge anti-science viewpoints within the administration.
The CDC has been experiencing significant turmoil, including the loss of over a quarter of its workforce and a succession of interim leaders. Public health experts voiced cautious optimism regarding Schwartz's qualifications but sought stronger assurances of her commitment to scientific independence. Schwartz pledged to uphold science but did not always provide definitive answers concerning specific political directives or past CDC actions.
Schwartz is the third nominee for CDC Director under the Trump administration within the last 18 months.